EHA is joining forces with the British Society of Haematology (BSH) & Annual Academy of Sickle Cell and Thalassaemia Conference (ASCAT) in organizing the 17th Annual Scientific Conference on Sickle Cell and Thalassaemia.
Abstract Submission is open. Click here to submit your abstract
Dates: January 26-28, 2022
The Annual Scientific Conference on Sickle Cell and Thalassaemia (ASCAT) focuses on promoting the latest advances in diagnosis, treatment, and emerging fields in hemoglobinopathies. It is an opportunity to interact with peers on the latest advances in clinical care, transition services, and emerging new therapies including updates for curative treatment options.
Abstract submission is an important part of this meeting. As a participant, you will have the opportunity to submit an abstract for this meeting, and (if accepted) have the possibility to discuss it with the international faculty and your peers.
Please select the most appropriate topic during the abstract & case submission:
- Basic and translational,
- Novel therapies, gene therapies, bone marrow transplant, and emerging diagnostics,
- Clinical and epidemiological studies,
- Infection, autoimmunity, nutritional deficiencies,
- Ageing and end organ damage,
- Health services and outcomes research including psychology.
Accepted abstracts may be presented as an oral presentation or e-poster.
|October 15, 2021||Start abstract & case submission|
|December 10, 2021||Deadline abstract & case submission|
|December 20, 2021||Notification of allocation to authors|
For any questions regarding the abstract submission process, please contact firstname.lastname@example.org.
Consultant Hematologists, Pediatricians, Specialist Nurses, Psychologists, Scientists, Fellows and trainees in all related fields
More details about registration will be published soon.
The full program will be published in the coming weeks.